Inicio>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Imipenem (hydrate)

Imipenem (hydrate) (Synonyms: NFormimidoyl Thienamycin)

Catalog No.GC43898

Imipenem (hidrato), un derivado cristalino estable de la tienamicina, es un antibiÓtico y tiene una excelente actividad contra una amplia gama de bacterias aerobias y anaerobias grampositivas y gramnegativas.

Products are for research use only. Not for human use. We do not sell to patients.

Imipenem (hydrate) Chemical Structure

Cas No.: 74431-23-5

Tamaño Precio Disponibilidad Cantidad
5mg
59,00 $
Disponible
10mg
81,00 $
Disponible
25mg
114,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Video Related Products

Imipenem monohydrate, a member of the carbapenem class of antibiotics isolated from the soil organism Streptomyces cattleya[1], is an intravenous β-lactam antibiotic effective against a wide range of Gram-positive and Gram-negative bacteria, including several multi-drug resistant bacterial species. Imipenem acts as cell wall-targeting antibiotic[2][3].

References:
[1]. Zhanel GG, et al. Imipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects. Can J Infect Dis. 1998 Jul;9(4):215-28.
[2]. Jacoby GA, et al. AmpC beta-lactamases. Clin Microbiol Rev. 2009 Jan;22(1):161-82.
[3]. Balibar CJ, et al. cwrA, a gene that specifically responds to cell wall damage in Staphylococcus aureus. Microbiology. 2010 May;156(Pt 5):1372-83.

Reseñas

Review for Imipenem (hydrate)

Average Rating: 5 ★★★★★ (Based on Reviews and 11 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Imipenem (hydrate)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.